prac.co/l/yexsvfxz (Practice Update paper, "ASTRO 2021: In HDRT for Localized Prostate Cancer, Long-Term Androgen Deprivation Fails to Compare Favorably to the Short-Term Alternative"
The footnote to the title is: "Lack of statistical significance may be due to shortcomings of the trial."
The conclusion seems to be that long-term ADT (24 months) is not superior to short-term ADT (4 months) when combined with high-dose RT. Problem I see is the results they give don't seem to show this. In each case, unless I'm misreading the results, the long term ADT treatment seems to give a 4-6% improvement in the outcome.
Am I misunderstanding this - or is it just a silly paper?